NASDAQ:ISRIsoRay Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding IsoRay, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.57 +0.01 (+1.78 %) (As of 07/6/2020 04:00 PM ET) Add Compare Share Today's Range$0.56Now: $0.57▼$0.5950-Day Range$0.56MA: $0.66▼$0.7552-Week Range$0.29Now: $0.57▼$1.06Volume159,426 shsAverage Volume542,246 shsMarket Capitalization$38.74 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartCompetitorsEarningsHeadlinesSocial Media IsoRay, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States. The company produces CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers, as well as ocular melanoma. It sells its products to facilities or physician practices that utilize multiple surgical facilities at which primarily prostate brachytherapy procedures are performed. The company was formerly known as Century Park Pictures Corporation and changed its name to IsoRay, Inc. in 2005. IsoRay, Inc. was founded in 1983 and is headquartered in Richland, Washington.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for IsoRay. Previous Next 3.1 Community Rank Outperform VotesIsoRay has received 5 “outperform” votes. (Add your “outperform” vote.)Underperform VotesIsoRay has received 3 “underperform” votes. (Add your “underperform” vote.)Community SentimentIsoRay has received 62.50% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about IsoRay and other stocks. Vote “Outperform” if you believe ISR will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ISR will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldIsoRay does not currently pay a dividend.Dividend GrowthIsoRay does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, IsoRay insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 3.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.62 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Medical Instruments & Supplies Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:ISR Previous Symbol CUSIPN/A CIKN/A Webwww.isoray.com Phone509-375-1202Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees43 Outstanding Shares67,651,000Market Cap$38.74 million Next Earnings Date9/22/2020 (Estimated) OptionableNot Optionable NASDAQ:ISR Rates by TradingView Receive ISR News and Ratings via Email Sign-up to receive the latest news and ratings for ISR and its competitors with MarketBeat's FREE daily newsletter. IsoRay (NASDAQ:ISR) Frequently Asked Questions How has IsoRay's stock been impacted by COVID-19 (Coronavirus)? IsoRay's stock was trading at $0.6706 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, ISR stock has decreased by 14.6% and is now trading at $0.5727. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of IsoRay? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for IsoRay in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for IsoRay. When is IsoRay's next earnings date? IsoRay is scheduled to release its next quarterly earnings announcement on Tuesday, September 22nd 2020. View our earnings forecast for IsoRay. How were IsoRay's earnings last quarter? IsoRay, Inc. (NASDAQ:ISR) released its quarterly earnings data on Tuesday, May, 12th. The company reported ($0.01) earnings per share (EPS) for the quarter, hitting the Zacks' consensus estimate of ($0.01). The business had revenue of $2.88 million for the quarter, compared to analysts' expectations of $2.76 million. View IsoRay's earnings history. Has IsoRay been receiving favorable news coverage? News headlines about ISR stock have trended negative this week, InfoTrie Sentiment reports. The research group identifies negative and positive news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. IsoRay earned a media sentiment score of -2.1 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View the latest news about IsoRay. Who are some of IsoRay's key competitors? Some companies that are related to IsoRay include CRH Medical (CRHM), CRH Medical (CRHM), SDI (SDI), Milestone Scientific (MLSS), Omega Diagnostics Group (ODX), Daxor (DXR), Daxor (DXR), TSO3 (TOS), Impression Healthcare (IHL), G Medical (GMV), TransEnterix (TRXC), Akers Biosciences (AKR), Relevium Technologies (RLV), Vigil Health Solutions (VGL) and Ambu A/S (AMBBY). View all competitors. What other stocks do shareholders of IsoRay own? Based on aggregate information from My MarketBeat watchlists, some companies that other IsoRay investors own include Workhorse Group (WKHS), Tonix Pharmaceuticals (TNXP), Nutra Pharma (NPHC), Miragen Therapeutics (MGEN), Moleculin Biotech (MBRX), Ibio (IBIO), Generex Biotechnology (GNBT), Ekso Bionics (EKSO), CAN-FITE BIOPHA/S (CANF) and BRK (BRKK). Who are IsoRay's key executives? IsoRay's management team includes the following people: Ms. Lori A. Holmes-Woods, CEO & Director (Age 58)Mr. Michael L. Krachon, VP of Sales & Marketing (Age 49)Mr. William A. Cavanagh III, Chief R&D Officer (Age 54)Mr. Jonathan R. Hunt, CFO & Co-Principal Financial Officer (Age 53)Ms. Jennifer Streeter, Interim COO & VP of HR (Age 50) What is IsoRay's stock symbol? IsoRay trades on the NASDAQ under the ticker symbol "ISR." How do I buy shares of IsoRay? Shares of ISR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is IsoRay's stock price today? One share of ISR stock can currently be purchased for approximately $0.57. How big of a company is IsoRay? IsoRay has a market capitalization of $38.74 million. IsoRay employs 43 workers across the globe. What is IsoRay's official website? The official website for IsoRay is www.isoray.com. How can I contact IsoRay? The company can be reached via phone at 509-375-1202. This page was last updated on 7/7/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
